These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32169103)

  • 1. Sema4A is implicated in the acceleration of Th17 cell-mediated neuroinflammation in the effector phase.
    Koda T; Namba A; Kinoshita M; Nakatsuji Y; Sugimoto T; Sakakibara K; Tada S; Shimizu M; Yamashita K; Takata K; Ishikura T; Murata S; Beppu S; Kumanogoh A; Mochizuki H; Okuno T
    J Neuroinflammation; 2020 Mar; 17(1):82. PubMed ID: 32169103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-β therapy in multiple sclerosis.
    Nakatsuji Y; Okuno T; Moriya M; Sugimoto T; Kinoshita M; Takamatsu H; Nojima S; Kimura T; Kang S; Ito D; Nakagawa Y; Toyofuku T; Takata K; Nakano M; Kubo M; Suzuki S; Matsui-Hasumi A; Uto-Konomi A; Ogata A; Mochizuki H; Sakoda S; Kumanogoh A
    J Immunol; 2012 May; 188(10):4858-65. PubMed ID: 22491253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis.
    Thakker P; Leach MW; Kuang W; Benoit SE; Leonard JP; Marusic S
    J Immunol; 2007 Feb; 178(4):2589-98. PubMed ID: 17277169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
    Chung CY; Liao F
    J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
    Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
    J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
    Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH
    J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sema4A as a biomarker predicting responsiveness to IFN β treatment].
    Nakatsuji Y
    Rinsho Shinkeigaku; 2014; 54(12):972-4. PubMed ID: 25519959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of fingolimod in MS patients with high serum Sema4A levels.
    Koda T; Namba A; Nakatsuji Y; Niino M; Miyazaki Y; Sugimoto T; Kinoshita M; Takata K; Yamashita K; Shimizu M; Fukazawa T; Kumanogoh A; Mochizuki H; Okuno T
    PLoS One; 2018; 13(3):e0193986. PubMed ID: 29518148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation.
    Cravens PD; Hussain RZ; Miller-Little WA; Ben LH; Segal BM; Herndon E; Stüve O
    PLoS One; 2016; 11(10):e0165248. PubMed ID: 27780253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Expression Levels of miR-29b-3p and miR-326 in T Helper-1 and T Helper-17 Cells Isolated from Responsive and Non-responsive Relapsing-remitting Multiple Sclerosis Patients Treated with Interferon-beta.
    Karimi L; Eskandari N; Shaygannejad V; Zare N; Andalib A; Khanahmad H; Mirmosayyeb O
    Iran J Allergy Asthma Immunol; 2020 Aug; 19(4):416-425. PubMed ID: 33463108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.
    Zhang X; Kiapour N; Kapoor S; Merrill JR; Xia Y; Ban W; Cohen SM; Midkiff BR; Jewells V; Shih YI; Markovic-Plese S
    Clin Immunol; 2018 Dec; 197():45-53. PubMed ID: 30149119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sema4A inhibits the therapeutic effect of IFN-β in EAE.
    Koda T; Okuno T; Takata K; Honorat JA; Kinoshita M; Tada S; Moriya M; Sakoda S; Mochizuki H; Kumanogoh A; Nakatsuji Y
    J Neuroimmunol; 2014 Mar; 268(1-2):43-9. PubMed ID: 24439904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
    de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
    Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
    Isaksson M; Lundgren BA; Ahlgren KM; Kämpe O; Lobell A
    Eur J Immunol; 2012 Oct; 42(10):2555-63. PubMed ID: 22806332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intercellular Adhesion Molecule-1 (ICAM-1) and ICAM-2 Differentially Contribute to Peripheral Activation and CNS Entry of Autoaggressive Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis.
    Haghayegh Jahromi N; Marchetti L; Moalli F; Duc D; Basso C; Tardent H; Kaba E; Deutsch U; Pot C; Sallusto F; Stein JV; Engelhardt B
    Front Immunol; 2019; 10():3056. PubMed ID: 31993059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GCN2 kinase plays an important role triggering the remission phase of experimental autoimmune encephalomyelitis (EAE) in mice.
    Orsini H; Araujo LP; Maricato JT; Guereschi MG; Mariano M; Castilho BA; Basso AS
    Brain Behav Immun; 2014 Mar; 37():177-86. PubMed ID: 24362236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
    Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
    J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.
    Teige I; Treschow A; Teige A; Mattsson R; Navikas V; Leanderson T; Holmdahl R; Issazadeh-Navikas S
    J Immunol; 2003 May; 170(9):4776-84. PubMed ID: 12707359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.